Market Update (NYSE:LLY): Eli Lilly wins UK Alimta drug patent case on appeal
June 25, 2015 at 06:44 AM EDT
[Reuters] – Eli Lilly has won a patent case in the Court of Appeal in London over its blockbuster Alimta lung cancer drug, boosting prospects for future sales and dealing a blow to . . . → Read More: Market Update (NYSE:LLY): Eli Lilly wins UK Alimta drug patent case on appeal Similar Articles: Company Update (NYSE:LLY): Eli Lilly loses Alimta drug patent case in Germany to Actavis Stock Update (NYSE:ACT): Eli Lilly loses Alimta drug patent case in Germany to Actavis Company Update (NYSE:LLY): Lilly delays submission to market once-daily diabetes drug